Cargando…

Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study

PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigne, Jonathan, Peyronnet, Damien, Leenhardt, Julien, Dubegny, Constance, Ardisson, Valérie, Pariscoat, Guillaume, Bolot, Claire, Rauscher, Aurore, Hallouard, François, Clave-Darcissac, Caroline, Clotagatide, Anthony, Odouard, Emmanuel, Faivre-Chauvet, Alain, Diehl, Justine, Houdu, Benjamin, Agostini, Denis, Morello, Rémy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224993/
https://www.ncbi.nlm.nih.gov/pubmed/34169368
http://dx.doi.org/10.1007/s00259-021-05361-9
_version_ 1783711997741760512
author Vigne, Jonathan
Peyronnet, Damien
Leenhardt, Julien
Dubegny, Constance
Ardisson, Valérie
Pariscoat, Guillaume
Bolot, Claire
Rauscher, Aurore
Hallouard, François
Clave-Darcissac, Caroline
Clotagatide, Anthony
Odouard, Emmanuel
Faivre-Chauvet, Alain
Diehl, Justine
Houdu, Benjamin
Agostini, Denis
Morello, Rémy
author_facet Vigne, Jonathan
Peyronnet, Damien
Leenhardt, Julien
Dubegny, Constance
Ardisson, Valérie
Pariscoat, Guillaume
Bolot, Claire
Rauscher, Aurore
Hallouard, François
Clave-Darcissac, Caroline
Clotagatide, Anthony
Odouard, Emmanuel
Faivre-Chauvet, Alain
Diehl, Justine
Houdu, Benjamin
Agostini, Denis
Morello, Rémy
author_sort Vigne, Jonathan
collection PubMed
description PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. METHODS: We retrospectively assessed the volume of planned examinations from 1 month before to 1 month after the first lockdown in French high-volume nuclear medicine departments (NMD) sharing the same information management system including both university hospitals, UH (n = 7), and cancer centres, CC (n = 2). RESULTS: The study enrolled 31,628 consecutive patients referred for a nuclear medicine examination performed or not (NMEP or NMEnP). The total volume of NMEP significantly dropped by 43.4% between the 4 weeks before and after the starting of the lockdown. The comparison of the percentage of NMEP and NMEnP between UH and CC is significantly different (p < 0.001). The percentage of NMEP during the study was 67.9% in UH vs 84.7% in CC. Percentages of NMEnP in UH and CC were due respectively to cancellation by the patient (14.9 vs 7.4%), cancellation by the NMD (9.5 vs 3.4%), cancellation by the referring physician (5.1 vs 4.4%) and non-attender patients (2.7 vs 0.2%). CONCLUSION: The study underlines the public health issue caused by COVID-19 above the pandemic itself and should be useful in preparing for potential resource utilisation and staffing requirements. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05361-9.
format Online
Article
Text
id pubmed-8224993
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-82249932021-06-25 Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study Vigne, Jonathan Peyronnet, Damien Leenhardt, Julien Dubegny, Constance Ardisson, Valérie Pariscoat, Guillaume Bolot, Claire Rauscher, Aurore Hallouard, François Clave-Darcissac, Caroline Clotagatide, Anthony Odouard, Emmanuel Faivre-Chauvet, Alain Diehl, Justine Houdu, Benjamin Agostini, Denis Morello, Rémy Eur J Nucl Med Mol Imaging Original Article PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic reshaped the usual risk: benefit equilibrium that became a trade-off between the infection exposure risk for the patient (and for staff) and the risk associated with delaying or cancelling the nuclear medicine examination. This study aimed at quantifying the impact of the first COVID-19 lockdown in France on nuclear medicine examination volume together with volume of examination cancellation and non-attendance. METHODS: We retrospectively assessed the volume of planned examinations from 1 month before to 1 month after the first lockdown in French high-volume nuclear medicine departments (NMD) sharing the same information management system including both university hospitals, UH (n = 7), and cancer centres, CC (n = 2). RESULTS: The study enrolled 31,628 consecutive patients referred for a nuclear medicine examination performed or not (NMEP or NMEnP). The total volume of NMEP significantly dropped by 43.4% between the 4 weeks before and after the starting of the lockdown. The comparison of the percentage of NMEP and NMEnP between UH and CC is significantly different (p < 0.001). The percentage of NMEP during the study was 67.9% in UH vs 84.7% in CC. Percentages of NMEnP in UH and CC were due respectively to cancellation by the patient (14.9 vs 7.4%), cancellation by the NMD (9.5 vs 3.4%), cancellation by the referring physician (5.1 vs 4.4%) and non-attender patients (2.7 vs 0.2%). CONCLUSION: The study underlines the public health issue caused by COVID-19 above the pandemic itself and should be useful in preparing for potential resource utilisation and staffing requirements. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-021-05361-9. Springer Berlin Heidelberg 2021-06-24 2021 /pmc/articles/PMC8224993/ /pubmed/34169368 http://dx.doi.org/10.1007/s00259-021-05361-9 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Vigne, Jonathan
Peyronnet, Damien
Leenhardt, Julien
Dubegny, Constance
Ardisson, Valérie
Pariscoat, Guillaume
Bolot, Claire
Rauscher, Aurore
Hallouard, François
Clave-Darcissac, Caroline
Clotagatide, Anthony
Odouard, Emmanuel
Faivre-Chauvet, Alain
Diehl, Justine
Houdu, Benjamin
Agostini, Denis
Morello, Rémy
Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study
title Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study
title_full Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study
title_fullStr Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study
title_full_unstemmed Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study
title_short Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study
title_sort quantitative impact of the first covid-19 lockdown on nuclear medicine in france: the coraline study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224993/
https://www.ncbi.nlm.nih.gov/pubmed/34169368
http://dx.doi.org/10.1007/s00259-021-05361-9
work_keys_str_mv AT vignejonathan quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT peyronnetdamien quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT leenhardtjulien quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT dubegnyconstance quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT ardissonvalerie quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT pariscoatguillaume quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT bolotclaire quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT rauscheraurore quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT hallouardfrancois quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT clavedarcissaccaroline quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT clotagatideanthony quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT odouardemmanuel quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT faivrechauvetalain quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT diehljustine quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT houdubenjamin quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT agostinidenis quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy
AT morelloremy quantitativeimpactofthefirstcovid19lockdownonnuclearmedicineinfrancethecoralinestudy